Search
Browse
Statistics
Feeds

Prominent mediatory role of gut microbiome in the effect of lifestyle on host metabolic phenotypes

[thumbnail of Publisher's Version]
Preview
PDF (Publisher's Version) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
7MB
[thumbnail of Supplemental Material] Other (Supplemental Material)
5MB

Item Type:Article
Title:Prominent mediatory role of gut microbiome in the effect of lifestyle on host metabolic phenotypes
Creators Name:Adriouch, Solia, Belda, Eugeni, Swartz, Timothy D., Forslund, Sofia, Prifti, Edi, Aron-Wisnewsky, Judith, Chakaroun, Rima, Nielsen, Trine, Poitou, Christine, Bel-Lassen, Pierre, Rouault, Christine, Le Roy, Tiphaine, Andrikopoulos, Petros, Chechi, Kanta, Puig-Castellví, Francesc, Dionicio, Inés Castro, Froguel, Philippe, Holmes, Bridget, Alili, Rohia, Andreelli, Fabrizio, Soula, Hedi, Salem, Joe-Elie, Falony, Gwen, Vieira-Silva, Sara, Raes, Jeroen, Bork, Peer, Stumvoll, Michael, Pedersen, Oluf, Ehrlich, S. Dusko, Dumas, Marc-Emmanuel, Oppert, Jean-Michel, Dao, Maria Carlota, Zucker, Jean-Daniel and Clément, Karine
Abstract:Lifestyle factors influence both gut microbiome composition and host metabolism, yet their combined and mediating effects on host phenotypes remain poorly characterized in cardiometabolic populations. In 1,643 participants from the MetaCardis study, we developed a composite lifestyle score (QASD: dietary quality, physical activity, smoking, and diet diversity) that outperformed individual lifestyle variables in explaining microbial gene richness and exhibited a significant impact on the gut microbiome composition. While bidirectional pathways linking the QASD score, host phenotypes, and microbiome composition were assessed, causal inference-based mediation analyses indicated stronger effects when the microbiome was modeled as the mediator variable, particularly in relation to the insulin resistance-associated profile. Microbiome gene richness emerged as a key mediator explaining 27.8% of QASD score’s effect on the insulin resistance marker (HOMA-IR), while no significant mediation was observed on BMI. Extended mediation analyses on microbial species and serum metabolomics deconfounded for drug use and clinical profiles identified 47 mediations where microbial taxa mediated more than 20% of the effect of the QASD score on serum metabolites associated with insulin resistance. Notably, several Faecalibacterium lineages enriched in individuals with high QASD score played a significant mediatory role in increasing the serum biomarkers of microbiome diversity (as cinnamoylglycine or 3- phenylpropionate). Conversely, elevated levels of secondary bile acids in individuals with low QASD scores were strongly mediated by high levels of Clostridium bolteae. These findings highlight distinct and clinically relevant microbiome pathways linking lifestyle behaviors to cardiometabolic risks. One sentence summary: The gut microbiome mediates the impact of diet quality and diversity, physical activity and smoking status – combined in a composite lifestyle score – on cardiometabolic phenotypes.
Keywords:Gut Microbiome, Nutrition, Lifestyle, Mediation
Source:Gut Microbes
ISSN:1949-0976
Publisher:Taylor & Francis
Volume:17
Number:1
Page Range:2599565
Date:2025
Official Publication:https://doi.org/10.1080/19490976.2025.2599565
PubMed:View item in PubMed
Related to:

Repository Staff Only: item control page

Downloads

Downloads per month over past year

Open Access
MDC Library